These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
479 related items for PubMed ID: 25541259
1. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, Kunisada T, Yano M, Kuji S, Hirashima Y, Arakawa A, Nishio S, Ushijima K, Ito K, Itani Y, Morishige K. Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259 [Abstract] [Full Text] [Related]
2. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium. Ruscito I, Cacsire Castillo-Tong D, Vergote I, Ignat I, Stanske M, Vanderstichele A, Ganapathi RN, Glajzer J, Kulbe H, Trillsch F, Mustea A, Kreuzinger C, Benedetti Panici P, Gourley C, Gabra H, Kessler M, Sehouli J, Darb-Esfahani S, Braicu EI. Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846 [Abstract] [Full Text] [Related]
3. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis. Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M, Saito T, Sato N. PLoS One; 2013 Jul; 8(6):e65158. PubMed ID: 23762304 [Abstract] [Full Text] [Related]
4. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC. Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226 [Abstract] [Full Text] [Related]
5. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling. Kim D, Choi BH, Ryoo IG, Kwak MK. Cell Death Dis; 2018 Aug 30; 9(9):896. PubMed ID: 30166520 [Abstract] [Full Text] [Related]
6. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas. Matsumoto T, Yokoi A, Hashimura M, Oguri Y, Akiya M, Saegusa M. Mol Carcinog; 2018 Aug 30; 57(8):957-967. PubMed ID: 29603383 [Abstract] [Full Text] [Related]
7. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics. Li D, Zhang T, Gu W, Li P, Cheng X, Tong T, Wang W. Oncol Rep; 2015 May 30; 33(5):2291-8. PubMed ID: 25760144 [Abstract] [Full Text] [Related]
8. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy. Sharrow AC, Perkins B, Collector MI, Yu W, Simons BW, Jones RJ. Gynecol Oncol; 2016 Aug 30; 142(2):341-8. PubMed ID: 27017984 [Abstract] [Full Text] [Related]
9. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W. Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217 [Abstract] [Full Text] [Related]
10. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance. Ahmed N, Abubaker K, Findlay J, Quinn M. J Cell Biochem; 2013 Jan 01; 114(1):21-34. PubMed ID: 22887554 [Abstract] [Full Text] [Related]
11. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation. Guo F, Yang Z, Kulbe H, Albers AE, Sehouli J, Kaufmann AM. Biomed Pharmacother; 2019 Oct 01; 118():109371. PubMed ID: 31545281 [Abstract] [Full Text] [Related]
12. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.]. Jing H, Liu XY, Chen YL, Bai LP, Zheng A. Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov 01; 47(6):878-882. PubMed ID: 28598117 [Abstract] [Full Text] [Related]
13. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J. J Clin Pathol; 2011 Nov 01; 64(11):937-46. PubMed ID: 21680574 [Abstract] [Full Text] [Related]
14. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ. Cancer Res; 2011 Jun 01; 71(11):3991-4001. PubMed ID: 21498635 [Abstract] [Full Text] [Related]
16. Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells. Upadhyaya B, Liu Y, Dey M. Int J Mol Sci; 2019 Feb 27; 20(5):. PubMed ID: 30818757 [Abstract] [Full Text] [Related]
17. High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion. Li Y, Chen T, Zhu J, Zhang H, Jiang H, Sun H. Biochem Biophys Res Commun; 2018 Jan 01; 495(1):1081-1088. PubMed ID: 29170132 [Abstract] [Full Text] [Related]
18. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma. Bartakova A, Michalova K, Presl J, Vlasak P, Kostun J, Bouda J. J Obstet Gynaecol; 2018 Jan 01; 38(1):110-114. PubMed ID: 28816557 [Abstract] [Full Text] [Related]